Biopharmaceutical organizations are seeking out ways to increase predictability in clonal material generated during cell line ...

Nova aims to quicken cell line development and create a stronger foundation for downstream process development, scaleup, and ...

Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology.

Avid Bioservices is a leading U.S.-based mammalian cell culture contract development and manufacturing organization (CDMO) providing integrated process development, analytical development, and CGMP ...

AbCellera’s T-cell engager (TCE) platform has reeled in a second client this summer, with Vertex Pharmaceuticals ...

Every embryo of an organism that reproduces sexually faces an early and consequential decision: which of its cell lineages will make up the mortal body, and which will become the germline, the lineage ...

CARLSBAD, Calif.-- (BUSINESS WIRE)--Jul 30, 2026-- ...

Delivery of the Bundibugyo viral antigens to Fondazione Biotecnopolo di Siena ('FBS”) and Scripps Research demonstrates C1's potential to accelerate vaccine and monoclonal antibody development, expand ...

Researchers say their achievement represents an important step toward the development of a new immunotherapy for solid tumors ...

Delivery of the Bundibugyo viral antigens to Fondazione Biotecnopolo di Siena ("FBS") and Scripps Research demonstrates C1's potential to accelerate vaccine and monoclonal antibody development, expand ...